Bahaa Mustafa

Assistant professor

University of Arkansas for Medical Sciences

faculty

bmustafa@uams.edu

4 h-index 16 pubs 88 cited

Research Areas

Cancer Immunotherapy and Biomarkers SARS-CoV-2 and COVID-19 Research Cancer Treatment and Pharmacology Immune Response and Inflammation Protein Structure and Dynamics Microbial infections and disease research Pancreatic and Hepatic Oncology Research

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Bahaa Mustafa's research focuses on developing novel therapeutic strategies for cancer immunotherapy and infectious diseases. His work has explored the discovery of peptide-based inhibitors targeting PD-L1 for cancer immunotherapy, as well as anti-ACE2 peptides to inhibit SARS-CoV-2 infectivity. Mustafa has also investigated human domain antibodies against PD-L1 and developed peptide-based tumor-activated checkpoint inhibitors. His recent publications examine enhancing immune response in hepatocellular carcinoma models using oncolytic viruses and immune checkpoint blockade, and improving the effectiveness of virotherapy in pancreatic cancer by targeting the tumor stroma. He has also explored multimodal reprogramming of the tumor microenvironment and synthetic oncolytic immunotherapy to address apoptotic resistance in pancreatic cancer. Mustafa collaborates with researchers at the University of Arkansas for Medical Sciences, including Mulu Z. Tesfay, Martin J. Cannon, and Khandoker Usran Ferdous, as well as Alexei G. Basnakian from Arkansas State University.

Metrics

  • h-index: 4
  • Publications: 16
  • Citations: 88

Selected Publications

  • Multimodal reprogramming of the tumor microenvironment by MMR and dual checkpoint blockade in hepatocellular carcinoma models (2025) DOI
  • Abstract B022: Reprogramming Apoptotic Resistance in PDAC Through Synthetic Oncolytic Immunotherapy (2025) DOI
  • Pancreatic tumor microenvironment reprogramming via alloantigen-expressing virotherapy elicits tumor rejection and improves immunotherapy response (2025) DOI
  • Abstract 2155: Phage display discovery of Trop-2 peptide for targeted liposomal chemo-immunotherapy in lung cancer (2025) DOI
  • Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models (2025) DOI
  • Abstract 947: Engineering a synthetic oncolytic virus to overcome apoptotic resistance and induce immunogenic cell death in pancreatic ductal adenocarcinoma (2025) DOI
  • Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade (2024) DOI
  • Anti-CD47 Peptide Combined with Oncolytic Vesiculovirus-Driven Intratumoral Immunotherapy for Colorectal Cancer (2024) DOI
  • Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer (2024) DOI

Collaborators

Researchers in the database who share publications

Mulu Z. Tesfay University of Arkansas for Medical Sciences 8 shared publications Martin J. Cannon University of Arkansas for Medical Sciences 7 shared publications Alexei G. Basnakian Arkansas State University 7 shared publications Khandoker Usran Ferdous University of Arkansas for Medical Sciences 7 shared publications Steven R. Post University of Arkansas for Medical Sciences 6 shared publications Camila Simões University of Arkansas for Medical Sciences 5 shared publications Randal S. Shelton University of Arkansas for Medical Sciences 5 shared publications Alicja Urbaniak University of Arkansas for Medical Sciences 4 shared publications

Similar Researchers

Based on overlapping research topics

Mulu Z. Tesfay University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers SARS-CoV-2 and COVID-19 Research Immune Response and Inflammation
Good match 5 shared topics
Martin J. Cannon University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers Cancer Treatment and Pharmacology Immune Response and Inflammation
Good match 5 shared topics
Steven R. Post University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers SARS-CoV-2 and COVID-19 Research Cancer Treatment and Pharmacology
Good match 5 shared topics
Eric Zini University of Arkansas at Monticello
SARS-CoV-2 and COVID-19 Research Cancer Treatment and Pharmacology Immune Response and Inflammation
Good match 5 shared topics
Pravin Parajuli National Center for Toxicological Research
SARS-CoV-2 and COVID-19 Research Immune Response and Inflammation Protein Structure and Dynamics
Good match 4 shared topics
Rang Govindarajan University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers Cancer Treatment and Pharmacology Immune Response and Inflammation
Good match 4 shared topics